Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours

Veterinary Research Communications

Volumn 38, Issue 1, 2014, Pages 21-27

  Enginler, S O ^a   Akis I ^a   Toydemir, T S F ^a   Oztabak, K ^a   Haktanir, D ^a   Gunduz M C ^a   Kirsan I ^a   Firat, I ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

BRCA1; BRCA2; Dog; Mammary tumour; Single nucleotide polymorphism

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER GROWTH; CONTROLLED STUDY; DOG DISEASE; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; INTRON; NONHUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; DOG DISEASES; DOGS; EXONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC VARIATION; MAMMARY NEOPLASMS, ANIMAL; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84896846009     PISSN: 01657380     EISSN: 15737446     Source Type: Journal    
DOI: 10.1007/s11259-013-9577-7     Document Type: Article

References (37)

1. Arnesen K, Gamlem H, Glattre E, Grøndalem J, Moe L, Nordstoga K (2001) The Norwegian canine cancer register 1990-1998. Report from the Project "Cancer in dog". EJCAP 11:159-169
2. Blencowe BJ (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trend Biochem Science 25:106-110
3. Borge KS, Børresen-Dale AL, Lingaas F (2011) Identification of genetic variation in 11 candidate genes of canine mammary tumour. Vet Comp Oncol 9(4):241-250
4. Cohen D, Reif JS, Brodey RS, Keiser H (1974) Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 34:2859-2868
5. Cotroneo MS, Haag JD, Zan Y, Lopez CC, Thuwajit P, Petukhova GV, Camerini-Otero RD, Gendron-Fitzpatrick A, Griep AE, Murphy CJ, Dubielzieg RR, Gould MN (2007) Characterizing a rat BRCA2 knockout model. Oncogene 26:1626-1635 (Pubitemid 46398744)
6. Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093 (Pubitemid 47014426)
7. Egenvall A, Bonnett BN, Ohage P, Olson P, Hedhammar A, von Euler H (2005) Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med 69:109-127 (Pubitemid 40717527)
8. Ensemble release 70 (2013) http://www.ensemble.org (accessed March 2013)
9. Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC (2005) CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434:598-604 (Pubitemid 40488546)
10. Fackenthal JD, Cartegni L, Krainer AR, Olopade OI (2002) BRCA2 T2722R is a deleterious allele that causes exon skipping. Am J Human Genet 71(3):625-631 (Pubitemid 34970133)
11. Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA (1998) BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:1009-1012 (Pubitemid 28399254)
12. Hsu WL, Huang YH, Chang TJ, Wong ML, Chang SC (2009) Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. Vet J 184:351-356
13. Judkins T, Hendrickson BC, Deffenbaugh AM, Scholl T (2005) Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutat Res 573:168-179
14. Kimchi-Safarty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A "silent" polymorphism in the MDR1 gene changes substrate specifity. Science 315:525-528 (Pubitemid 46175758)
15. Komar AA (2007) Genetics. SNPs, silent but not invisible. Science 315:466-467
16. Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27(1):55-58 (Pubitemid 32044518)
17. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
18. Mizuta R, LaSalle JM, Cheng HL, Shinohara A, Ogawa H, Copeland N, Jenkins NA, Lalande M, Alt FW (1997) RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. PNAS 94:6927-6932 (Pubitemid 27281967)
19. Moe L (2001) Population-based incidence of mammary tumours in some dog breeds. J Reprod Fertil Suppl 57:439-443
20. Mooney S (2005) Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis. Brief Bioinform 6(1):44-56
21. Moulton JE, Taylor DO, Dorn CR, Andersen AC (1970) Canine mammary tumours. Vet Pathol 7:289-320
22. Ochiai K, Morimatsu M, Yoshikawa Y, Syuto B, Hashizume K (2004) Brca2 C-terminus interacts with Rad51 and contributes to nuclear focus formation in double-strand break repair of DNA. Biomed Res 25:269-275 (Pubitemid 41520003)
23. Orban TI, Olah E (2001) Purifying selection on silent sites - a constraint from splicing regulation? Trends Genet 17(5):252-253
24. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of bRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. JNCI 91:943-949 (Pubitemid 29272520)
25. Phillips KA, Andrulis IL, Goodwin PJ (1999) Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different? JCO 17:3653-3663 (Pubitemid 29517937)
26. Pyne MT (2000) Characterization of intronic variants in BRCA1 and BRCA2. Master of Science Thesis, The University of Utah, Department of Pathology
27. Rivera P, Melin M, Biagi T, Fall T, Häggsström J, Lindblad-Toh K, von Euler H (2009) Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res 69(22):8770-8774
28. Scully R, Livingston DM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429-432
29. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 inmice lacking Brca2. Nature 386:804-810 (Pubitemid 27181248)
30. Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM (1999) Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. PNAS 96:13920-13925
31. Szabo CI, Wagner LA, Francisco LV, Roach JC, Argonza R, King M, Ostrander EA (1996) Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 5(9):1289-1298 (Pubitemid 26335846)
32. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599 (Pubitemid 47236692)
33. Ventikaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182
34. Yano K, Morotomi K, Saito H, Kato M, Matsuo F, Miki Y (2000) Nuclear localization signals of the BRCA2 protein. Biochem Biophys Res Commun 270:171-175 (Pubitemid 30440411)
35. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N, Hashizume K (2005a) Insertion/deletion polymorphism in the BRCA2 nuclear localization signal. Biomed Res 26:109-116 (Pubitemid 41519983)
36. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N, Hashizume K (2005b) Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus. JVMS 67:1013-1017 (Pubitemid 41634658)
37. Yoshikawa Y, Morimatsu M, Ochiai K, Okuda K, Takahiro T, Chikazawa S, Shimamura A, Omi T, Bonkobara M, Orino K, Watanabe K (2012) Establishment of a PCR analysis method for canine BRCA2. BMC Res Notes 5:173